ACCENDRA HEALTH INC quarterly report, Q3 FY2018

Owens & Minor, Inc. — Form 10-Q summary

Company identification: The supplied filing is for Owens & Minor, Inc., although the request metadata names ACCENDRA HEALTH INC. The filing covers the quarter and nine months ended September 30, 2018; amounts below are in millions unless stated otherwise.

Business context and reporting period

Owens & Minor distributes healthcare products and provides logistics and related services through Global Solutions, and sells product-related solutions through Global Products. The company acquired Avanos Medical’s Surgical and Infection Prevention business (Halyard) on April 30, 2018, and includes it in Global Products. It also acquired Byram Healthcare in August 2017. The company reorganized its reporting into these two segments in 2018 and recast prior-year segment results.

Financial results and liquidity

MetricQ3 2018Q3 2017Nine months 2018Nine months 2017
Revenue$2,464.9$2,334.0$7,295.7$6,928.4
Gross margin$352.6; 14.30%$301.9; 12.94%$1,002.3; 13.74%$856.7; 12.36%
Operating income (loss)$21.4$29.7$(126.5)$98.0
Net income (loss)$(0.6)$10.9$(175.2)$49.8
Diluted EPS$(0.01)$0.18$(2.92)$0.82
Interest expense, net$23.8$8.7$52.7$22.2

Management’s non-GAAP adjusted EPS was $0.32 for Q3 and $1.06 year to date, versus $0.40 and $1.26, respectively, in 2017; these measures exclude specified items and should be considered alongside GAAP results.

  • Segment performance: Q3 Global Solutions operating income was $24.2, down $13.4 year over year, reflecting provider-margin pressure and warehouse inefficiencies, partly offset by Byram. Global Products operating income was $27.6, up $17.1, primarily reflecting Halyard. Year-to-date operating income was $84.7 for Global Solutions and $61.4 for Global Products.
  • Cash flow: Nine-month operating cash flow was $122.5, compared with $5.6 in 2017; management attributed the improvement primarily to working-capital changes. Investing cash outflow was $798.9, including the $758.0 Halyard acquisition. Financing cash inflow was $695.2. Cash rose to $124.9 from $104.5 at year-end 2017.
  • Balance sheet and debt: Current assets were $2,492.9 and current liabilities $1,456.7 at September 30, 2018. Long-term debt, excluding current portion, was $1,640.5; the filing also describes approximately $1.7 billion of aggregate secured debt. Cash and unused revolver availability were $124.9 and $406.7, respectively. Total equity was $792.4, down from $1,015.5 at year-end.
  • Working capital: Receivables were $870.2, inventories $1,203.8, and accounts payable $1,107.5. DSO rose to 31.1 from 28.7 days and inventory turnover fell to 6.9 from 8.5.

Material changes, outlook, and risks

  • Revenue increased 5.6% in Q3 and 5.3% year to date, with growth substantially reflecting acquired businesses. Byram contributed $141.5 of Q3 revenue and $387.3 year to date; Halyard contributed $239.6 and $407.6, respectively. Global Solutions revenue declined 2.1% in Q3, including the effects of lost customers.
  • Year-to-date GAAP results included $165.4 of goodwill and intangible-asset impairment charges: approximately $149.0 for kitting-business goodwill and $16.5 for customer relationships. The company cited customer losses, operational inefficiencies, weaker-than-projected results, and a decline in its market capitalization as impairment indicators.
  • Gross margin improved year over year, but management expects provider-margin pressure to continue amid customer cost pressures and competition. Higher LIFO provision reduced gross margin by $6.6 in Q3 and $13.5 year to date versus 2017. DS&A costs also rose, including higher warehouse and delivery expenses.
  • Halyard’s $758.0 acquisition was funded in part through amended credit facilities, including a $500.0 Term B loan and a $195.8 Term A-2 loan. The company reported compliance with debt covenants at September 30, 2018. Variable-rate borrowing, restrictive covenants, and springing-maturity provisions are relevant debt risks.
  • Management said available cash and financing sources should be sufficient for foreseeable needs, but provided no specific earnings or revenue guidance in the supplied filing text. It identified risks including pricing and margin pressure, customer and supplier concentration, acquisition integration, operational inefficiencies, leverage and interest rates, regulatory and reimbursement changes, commodity costs, and information-system or cybersecurity disruptions.
  • The company expects the new lease-accounting standard, effective January 1, 2019, to materially affect the balance sheet through recognition of operating-lease right-of-use assets and liabilities. Disclosure controls were deemed effective; the acquired Halyard business was excluded from management’s evaluation of internal control over financial reporting for this period. No material developments in previously reported legal proceedings were noted.

Important facts for investors to verify

  • Whether Halyard integration delivers expected benefits and whether its preliminary purchase-price allocation or acquisition-related costs change.
  • Whether customer losses, provider-margin pressure, warehouse inefficiencies, or further impairments affect future segment performance.
  • Debt principal, maturity and covenant headroom, interest-rate exposure, and the sustainability of operating cash flow after acquisition spending.
  • Whether working-capital trends—especially rising DSO and lower inventory turnover—improve, and the eventual balance-sheet impact of lease adoption.
  • The filing’s stated issuer is Owens & Minor, Inc.; verify the apparent difference from the company named in the request metadata.